These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 28629761)

  • 1. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
    Cappuzzello E; Sommaggio R; Zanovello P; Rosato A
    Cytokine Growth Factor Rev; 2017 Aug; 36():99-105. PubMed ID: 28629761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.
    Giraudo L; Gammaitoni L; Cangemi M; Rotolo R; Aglietta M; Sangiolo D
    Immunotherapy; 2015; 7(9):999-1010. PubMed ID: 26310715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
    Wu X; Sharma A; Oldenburg J; Weiher H; Essler M; Skowasch D; Schmidt-Wolf IGH
    Front Immunol; 2021; 12():731767. PubMed ID: 34691037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric antigen receptor-engineered cytokine-induced killer cells overcome treatment resistance of pre-B-cell acute lymphoblastic leukemia and enhance survival.
    Oelsner S; Wagner J; Friede ME; Pfirrmann V; Genßler S; Rettinger E; Buchholz CJ; Pfeifer H; Schubert R; Ottmann OG; Ullrich E; Bader P; Wels WS
    Int J Cancer; 2016 Oct; 139(8):1799-809. PubMed ID: 27253354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 enhances cytokine induced killer (CIK) cytotoxic potential against epithelial cancer cell lines via an innate pathway.
    Iudicone P; Fioravanti D; Cicchetti E; Zizzari IG; Pandolfi A; Scocchera R; Fazzina R; Pierelli L
    Hum Immunol; 2016 Dec; 77(12):1239-1247. PubMed ID: 27615504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten-year update of the international registry on cytokine-induced killer cells in cancer immunotherapy.
    Zhang Y; Schmidt-Wolf IGH
    J Cell Physiol; 2020 Dec; 235(12):9291-9303. PubMed ID: 32484595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer.
    Dehno MN; Li Y; Weiher H; Schmidt-Wolf IGH
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
    Sommaggio R; Cappuzzello E; Dalla Pietà A; Tosi A; Palmerini P; Carpanese D; Nicolè L; Rosato A
    Oncoimmunology; 2020 Jun; 9(1):1777046. PubMed ID: 32923140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
    Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D
    Expert Opin Biol Ther; 2012 Jun; 12(6):673-84. PubMed ID: 22500889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic potential of IL-15-activated cytokine-induced killer cells against human neuroblastoma cells.
    Cappel C; Huenecke S; Suemmerer A; Erben S; Rettinger E; Pfirrmann V; Heinze A; Zimmermann O; Klingebiel T; Ullrich E; Bader P; Bremm M
    Pediatr Blood Cancer; 2016 Dec; 63(12):2230-2239. PubMed ID: 27433920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition.
    Wei F; Rong XX; Xie RY; Jia LT; Wang HY; Qin YJ; Chen L; Shen HF; Lin XL; Yang J; Yang S; Hao WC; Chen Y; Xiao SJ; Zhou HR; Lin TY; Chen YS; Sun Y; Yao KT; Xiao D
    Oncotarget; 2015 Oct; 6(33):35023-39. PubMed ID: 26418951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies.
    Ghanbari Sevari F; Mehdizadeh A; Abbasi K; Hejazian SS; Raeisi M
    Stem Cell Res Ther; 2024 Aug; 15(1):254. PubMed ID: 39135188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo allogeneic stimulation significantly improves expansion of cytokine-induced killer cells without increasing their alloreactivity across HLA barriers.
    Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D
    J Immunother; 2012 Sep; 35(7):579-86. PubMed ID: 22892454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can Cytokine-induced killer cells overcome CAR-T cell limits.
    Cappuzzello E; Vigolo E; D'Accardio G; Astori G; Rosato A; Sommaggio R
    Front Immunol; 2023; 14():1229540. PubMed ID: 37675107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of cytokine-induced killer cells with folate receptor alpha (FRα)-specific chimeric antigen receptors enhances their antitumor immunity toward FRα-positive ovarian cancers.
    Zuo S; Wen Y; Panha H; Dai G; Wang L; Ren X; Fu K
    Mol Immunol; 2017 May; 85():293-304. PubMed ID: 28360017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arming cytokine-induced killer cells with chimeric antigen receptors: CD28 outperforms combined CD28-OX40 "super-stimulation".
    Hombach AA; Rappl G; Abken H
    Mol Ther; 2013 Dec; 21(12):2268-77. PubMed ID: 23985696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells.
    Bremm M; Pfeffermann LM; Cappel C; Katzki V; Erben S; Betz S; Quaiser A; Merker M; Bonig H; Schmidt M; Klingebiel T; Bader P; Huenecke S; Rettinger E
    Front Immunol; 2019; 10():1218. PubMed ID: 31214182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignancies.
    Ren X; Ma W; Lu H; Yuan L; An L; Wang X; Cheng G; Zuo S
    Cancer Immunol Immunother; 2015 Dec; 64(12):1517-29. PubMed ID: 26386966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy against sarcomas.
    Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D
    Expert Opin Biol Ther; 2015 Apr; 15(4):517-28. PubMed ID: 25516119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.